# Fedor Moiseenko

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/fedor-moiseenko/

## Facts

| Field | Value |
| --- | --- |
| Citations | 33,670 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 36 |
| i10-index | 52 |
| Last Known Institution | Leningrad Regional Cancer Center |
| OpenAlex ID | https://openalex.org/A5031362509 |
| ORCID iD | 0000-0003-2544-9042 |
| Works | 216 |

## Researcher papers

- [Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer](https://scholariq.org/papers/effect-of-first-line-serplulimab-vs-placebo-added-to-chemotherapy-on-survival-in/)
- [Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Nonsquamous <i>EGFR</i> -Wildtype Non–Small Cell Lung Cancer in the Phase II LUMINOSITY Trial](https://scholariq.org/papers/telisotuzumab-vedotin-monotherapy-in-patients-with-previously-treated-c-met/)
- [Investigation of the mechanisms of resistance to osimertinib in patients with T790M-associated NSCLC](https://scholariq.org/papers/investigation-of-the-mechanisms-of-resistance-to-osimertinib-in-patients-with/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)

## Researcher university

- [Leningrad Regional Cancer Center](https://scholariq.org/institutions/leningrad-regional-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.